Literature DB >> 16761717

Isolation of stromal stem cells from human adipose tissue.

Andrew C Boquest1, Aboulghassem Shahdadfar, Jan E Brinchmann, Philippe Collas.   

Abstract

The stromal compartment of mesenchymal tissues is thought to harbor stem cells that display extensive proliferative capacity and multilineage potential. Stromal stem cells offer a potentially large therapeutic potential in the field of regenerative medicine. Adipose tissue contains a large number of stromal stem cells, is relatively easy to obtain in large quantities, and thus constitutes a very convenient source of stromal stem cells. Importantly, the number of stem cells obtained is compatible with extensive analyses of the cells in an uncultured, freshly isolated, form. This chapter describes procedures for isolating millions of highly purified stromal stem cells from human adipose tissue and methods of establishing polyclonal and monoclonal cultures of adipose tissue-derived stem cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16761717     DOI: 10.1385/1-59745-005-7:35

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  41 in total

Review 1.  The potential of adipose stem cells in regenerative medicine.

Authors:  Bettina Lindroos; Riitta Suuronen; Susanna Miettinen
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

2.  Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis.

Authors:  Bo Ri Seo; Priya Bhardwaj; Siyoung Choi; Jacqueline Gonzalez; Roberto C Andresen Eguiluz; Karin Wang; Sunish Mohanan; Patrick G Morris; Baoheng Du; Xi K Zhou; Linda T Vahdat; Akanksha Verma; Olivier Elemento; Clifford A Hudis; Rebecca M Williams; Delphine Gourdon; Andrew J Dannenberg; Claudia Fischbach
Journal:  Sci Transl Med       Date:  2015-08-19       Impact factor: 17.956

3.  Manual isolation of adipose-derived stem cells from human lipoaspirates.

Authors:  Min Zhu; Sepideh Heydarkhan-Hagvall; Marc Hedrick; Prosper Benhaim; Patricia Zuk
Journal:  J Vis Exp       Date:  2013-09-26       Impact factor: 1.355

4.  cAMP-mediated induction of cyclin E sensitizes growth-arrested adipose stem cells to DNA damage-induced apoptosis.

Authors:  Hege Ugland; Andrew C Boquest; Soheil Naderi; Philippe Collas; Heidi Kiil Blomhoff
Journal:  Mol Biol Cell       Date:  2008-09-17       Impact factor: 4.138

Review 5.  Vibration stimuli and the differentiation of musculoskeletal progenitor cells: Review of results in vitro and in vivo.

Authors:  Jennifer Helen Edwards; Gwendolen Clair Reilly
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

6.  Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.

Authors:  Ioannis Christodoulou; Maria Goulielmaki; Marina Devetzi; Mihalis Panagiotidis; Georgios Koliakos; Vassilis Zoumpourlis
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

Review 7.  Adipose mesenchymal stem cells in the field of bone tissue engineering.

Authors:  Cecilia Romagnoli; Maria Luisa Brandi
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

8.  Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90.

Authors:  Banafsheh Nazari; Lisa M Rice; Giuseppina Stifano; Alexander M S Barron; Yu Mei Wang; Tess Korndorf; Jungeun Lee; Jag Bhawan; Robert Lafyatis; Jeffrey L Browning
Journal:  Am J Pathol       Date:  2016-08-23       Impact factor: 4.307

9.  Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype.

Authors:  Oluf Dimitri Røe; Endre Anderssen; Eli Helge; Caroline Hild Pettersen; Karina Standahl Olsen; Helmut Sandeck; Rune Haaverstad; Steinar Lundgren; Erik Larsson
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240

10.  A molecular function map of Ewing's sarcoma.

Authors:  Maximilian Kauer; Jozef Ban; Reinhard Kofler; Bob Walker; Sean Davis; Paul Meltzer; Heinrich Kovar
Journal:  PLoS One       Date:  2009-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.